These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 11713097

  • 1. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
    Cao XX, Mohuiddin I, Ece F, McConkey DJ, Smythe WR.
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):562-8. PubMed ID: 11713097
    [Abstract] [Full Text] [Related]

  • 2. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
    Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe WR.
    Cancer Gene Ther; 2001 Aug; 8(8):547-54. PubMed ID: 11571532
    [Abstract] [Full Text] [Related]

  • 3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM.
    J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6504-15. PubMed ID: 14695155
    [Abstract] [Full Text] [Related]

  • 5. Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.
    Smythe WR, Mohuiddin I, Ozveran M, Cao XX.
    J Thorac Cardiovasc Surg; 2002 Jun 15; 123(6):1191-8. PubMed ID: 12063468
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
    Saltzman A, Munro R, Searfoss G, Franks C, Jaye M, Ivashchenko Y.
    Exp Cell Res; 1998 Jul 10; 242(1):244-54. PubMed ID: 9665822
    [Abstract] [Full Text] [Related]

  • 7. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T, Murakami K, Takimoto R, Takahashi M, Takada K, Murakami T, Minami S, Matsunaga T, Takayama T, Kato J, Niitsu Y.
    Cancer Res; 2003 Dec 15; 63(24):8948-54. PubMed ID: 14695212
    [Abstract] [Full Text] [Related]

  • 8. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.
    Invest Ophthalmol Vis Sci; 2003 Jun 15; 44(6):2390-8. PubMed ID: 12766035
    [Abstract] [Full Text] [Related]

  • 9. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V, Slomianny C, Hondermarck H, Le Bourhis X.
    Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702
    [Abstract] [Full Text] [Related]

  • 10. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY, Stein CA.
    Clin Cancer Res; 1997 Nov 15; 3(11):2039-46. PubMed ID: 9815595
    [Abstract] [Full Text] [Related]

  • 11. Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells.
    Shima Y, Nakao K, Nakashima T, Kawakami A, Nakata K, Hamasaki K, Kato Y, Eguchi K, Ishii N.
    Hepatology; 1999 Nov 15; 30(5):1215-22. PubMed ID: 10534343
    [Abstract] [Full Text] [Related]

  • 12. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 15; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 13. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.
    Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL.
    Cao XX, Mohuiddin I, Chada S, Mhashilkar AM, Ozvaran MK, McConkey DJ, Miller SD, Daniel JC, Smythe WR.
    Mol Med; 2002 Dec 01; 8(12):869-76. PubMed ID: 12606823
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu.
    Schuster N, Bender H, Philippi A, Subramaniam S, Strelau J, Wang Z, Krieglstein K.
    Glia; 2002 Oct 01; 40(1):95-108. PubMed ID: 12237847
    [Abstract] [Full Text] [Related]

  • 17. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Zushi S, Kitamura S, Ueyama H, Matsuzawa Y.
    Oncogene; 1998 Nov 19; 17(20):2585-91. PubMed ID: 9840921
    [Abstract] [Full Text] [Related]

  • 18. Activation and relocalization of caspase 3 during the apoptotic cascade of human mesothelioma cells.
    Soini Y, Kahlos K, Sormunen R, Säily M, Mäntymaa P, Koistinen P, Pääkkö P, Kinnula V.
    APMIS; 2005 Jun 19; 113(6):426-35. PubMed ID: 15996160
    [Abstract] [Full Text] [Related]

  • 19. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S, Gupta S.
    J Immunol; 1998 Feb 15; 160(4):1627-37. PubMed ID: 9469419
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B.
    Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.